V
Vanessa Selak
Researcher at University of Auckland
Publications - 36
Citations - 932
Vanessa Selak is an academic researcher from University of Auckland. The author has contributed to research in topics: Medicine & Polypill. The author has an hindex of 14, co-authored 23 publications receiving 814 citations. Previous affiliations of Vanessa Selak include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Danazol for pelvic pain associated with endometriosis
TL;DR: Treatment with danazol was effective in relieving painful symptoms related to endometriosis when compared to placebo, however, its use is limited by the occurrence of androgenic side effects.
Journal ArticleDOI
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care
Vanessa Selak,C Raina Elley,Chris Bullen,Sue Crengle,Angela Wadham,Natasha Rafter,Varsha Parag,Matire Harwood,Robert N. Doughty,Bruce Arroll,Richard J. Milne,Dale Bramley,Linda Bryant,Rod Jackson,Anthony Rodgers +14 more
TL;DR: Adherence to all four recommended drugs was greater among fixed dose combination than usual care participants at 12 months and there was no statistically significant improvement in risk factor control between the fixed doses and usual care groups over 12 months.
Journal ArticleDOI
Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
Sue Wells,Sue Furness,Natasha Rafter,Elaine Horn,Robyn Whittaker,Alistair W. Stewart,Kate Moodabe,Paul Roseman,Vanessa Selak,Dale Bramley,Rod Jackson +10 more
TL;DR: It is demonstrated that integrated electronic decision support can quadruple CVD risk assessment in just one cycle of patient visits, suggesting that previous strategies were ineffective.
Journal ArticleDOI
Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries☆ , ☆☆
Ruth Webster,Anushka Patel,Vanessa Selak,Laurent Billot,Michiel L. Bots,Alex Brown,Chris Bullen,Alan Cass,Sue Crengle,C Raina Elley,Diederick E. Grobbee,Bruce Neal,David Peiris,Neil R Poulter,Dorairaj Prabhakaran,Natasha Rafter,Alice Stanton,Sandrine Stepien,Simon Thom,Tim Usherwood,Angela Wadham,Anthony Rodgers +21 more
TL;DR: Polypill therapy significantly improved adherence, SBP and LDL-cholesterol in high risk patients compared with usual care, especially among those who were under-treated at baseline.
Journal ArticleDOI
The Efficacy and Tolerability of ‘Polypills’: Meta-Analysis of Randomised Controlled Trials
C Raina Elley,Ajay Gupta,Ruth Webster,Vanessa Selak,Min Jun,Anushka Patel,Anthony Rodgers,Simon Thom +7 more
TL;DR: There was high statistical heterogeneity in comparisons for blood pressure and lipid-lowering but use of random-effects and quality-effects models produced very similar results.